Individual timing of blood counts in G-CSF prophylaxis after myelosuppressive chemotherapy reduces G-CSF injections, blood counts, and costs: a prospective randomized study in children and adolescents.

MLA

Ammann, Roland, et al. “Individual Timing of Blood Counts in G-CSF Prophylaxis after Myelosuppressive Chemotherapy Reduces G-CSF Injections, Blood Counts, and Costs: A Prospective Randomized Study in Children and Adolescents.” Supportive Care in Cancer, vol. 10, no. 8, Nov. 2002, pp. 613–18. EBSCOhost, https://doi.org/10.1007/s00520-002-0365-0.

APA

Ammann, R., Leibundgut, K., Hirt, A., & Ridolfi Lüthy, A. (2002). Individual timing of blood counts in G-CSF prophylaxis after myelosuppressive chemotherapy reduces G-CSF injections, blood counts, and costs: a prospective randomized study in children and adolescents. Supportive Care in Cancer, 10(8), 613–618. https://doi.org/10.1007/s00520-002-0365-0

Chicago

Ammann, Roland, Kurt Leibundgut, Andreas Hirt, and Annette Ridolfi Lüthy. 2002. “Individual Timing of Blood Counts in G-CSF Prophylaxis after Myelosuppressive Chemotherapy Reduces G-CSF Injections, Blood Counts, and Costs: A Prospective Randomized Study in Children and Adolescents.” Supportive Care in Cancer 10 (8): 613–18. doi:10.1007/s00520-002-0365-0.